v3.26.3
Segment Information (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Operations by Reportable Segment

 

Three Months Ended September 30, 2026  Product Packaging   Commercial Lending   Biotechnology   Securities and
Investment
Management		   Corporate/
Other		   Total 
Revenue  $3,371,000   $5,000   $21,000   $207,000   $-   $3,604,000 
Cost of Revenue   3,741,000    (28,000)   6,000    1,131,000    -    4,850,000 
Gross profit (loss)   (370,000)   33,000    15,000    (924,000)   -    (1,246,000)
Operating expense   778,000    71,000    682,000    625,000    770,000    2,926,000 
Operating loss   (1,148,000)   (38,000)   (667,000)   (1,549,000)   (770,000)   (4,172,000)
Other income (expense)   (61,000)   (900,000)   4,000    604,000    (513,000)   (866,000)
Net loss from operations before taxes   (1,209,000)   (938,000)   (663,000)   (945,000)   (1,283,000)   (5,038,000)

 

Three Months Ended September 30,2025  Product Packaging   Commercial Lending   Biotechnology   Securities
and
Investment
Management		   Corporate/
Other		   Total 
Revenue  $4,935,000   $7,000   $11,000   $1,439,000   $-   $6,392,000 
Cost of revenue   4,380,000    (192,000)   2,000    1,868,000    -    6,058,000 
Gross profit (loss)   555,000    199,000    (1,000)   (429,000)   -    324,000 
Operating expense   894,000    57,000    883,000    (1,754,000)   3,478,000    3,558,000 
Operating income (loss)   (339,000)   142,000    (884,000)   1,325,000    (3,478,000)   (3,234,000)
Other income (expense)   (35,000)   370,000    3,000    609,000    58,000    1,005,000 
Net income (loss) from operations before taxes   (374,000)   512,000    (881,000)   1,934,000    (3,420,000)   (2,229,000)

 

Nine Months Ended September 30, 2026  Product Packaging   Commercial Lending   Biotechnology   Securities
and
Investment
Management		   Corporate/
Other		   Total 
Revenue  $10,808,000   $17,000   $31,000   $682,000   $-   $11,538,000 
Cost of Revenue   11,536,000    (28,000)   8,000    3,386,000    -    14,902,000 
Gross profit (loss)   (728,000)   45,000    23,000    (2,704,000)   -    (3,364,000)
Operating expense   2,550,000    242,000    3,686,000    1,274,000    2,330,000    10,082,000 
Operating loss   (3,278,000)   (197,000)   (3,663,000)   (3,978,000)   (2,330,000)   (13,446,000)
Other income (expense)   (120,000)   (855,000)   10,000    765,000    (2,665,000)   (2,865,000)
Net loss from operations before taxes  $(3,398,000)  $(1,052,000)  $(3,653,000)  $(3,213,000)  $(4,995,000)  $(16,311,000)

 

 

Nine Months Ended September 30,2025  Product Packaging   Commercial Lending   Biotechnology   Securities
and
Investment
Management		   Corporate/
Other		   Total 
Revenue  $13,221,000   $37,000   $32,000   $3,340,000   $-   $16,630,000 
Cost of revenue   12,274,000    20,000    36,000    4,430,000    (7,000)   16,753,000 
Gross profit (loss)   947,000    17,000    (4,000)   (1,090,000)   7,000    (123,000)
Operating expense   2,357,000    197,000    3,124,000    (855,000)   5,438,000    10,261,000 
Operating loss   (1,410,000)   (180,000)   (3,128,000)   (235,000)   (5,431,000)   (10,384,000)
Other income (expense)   (110,000)   (46,000)   49,000    (318,000)   655,000    230,000 
Net loss from operations before taxes  $(1,520,000)  $(220,000)  $(3,079,000)  $(553,000)  $(4,776,000)  $(10,154,000)
Schedule of Disaggregation of Revenue

The following tables disaggregate our business segment revenues by major source:

 

Printed Products Revenue Information:

 

Three months ended September 30, 2026    
Packaging Printing and Fabrication  $3,336,000 
Commercial and Security Printing   35,000 
Total Printed Products Revenue  $3,371,000 

 

Three months ended September 30, 2025    
Packaging Printing and Fabrication  $4,841,000 
Commercial and Security Printing   78,000 
Real Property Rental   16,000 
Total Printed Products Revenue  $4,935,000 

 

Nine months ended September 30, 2026    
Packaging Printing and Fabrication  $10,402,000 
Commercial and Security Printing   375,000 
Real Property Rental   31,000 
Total Printed Products Revenue  $10,808,000 

 

Nine months ended September 30, 2025    
Packaging Printing and Fabrication  $12,839,000 
Commercial and Security Printing   334,000 
Real Property Rental   48,000 
Total Printed Products Revenue  $13,221,000 

 

Commercial Lending Revenue Information:

 

Three months ended September 30, 2026    
Net investment  $5,000 
Total Commercial Lending Revenue  $5,000 

 

Three months ended September 30, 2025    
Net Investment  $7,000 
Total Commercial Lending Revenue  $7,000 

 

Nine months ended September 30, 2026    
Net investment  $17,000 
Total Commercial Lending Revenue  $17,000 

 

Nine months ended September 30, 2025    
Net Investment  $37,000 
Total Commercial Lending Revenue  $37,000 

 

Biotechnology Revenue Information:

 

     
Three months ended September 30, 2026    
Retail internet sales   21,000 
Total Biotechnology Revenue  $21,000 

 

Three months ended September 30, 2025    
Retail internet sales  $11,000 
Total Biotechnology Revenue  $11,000 

 

Nine months ended September 30, 2026    
Retail internet sales   31,000 
Total Biotechnology Revenue  $31,000 

 

 

Nine months ended September 30, 2025    
Retail internet sales  $32,000 
Total Biotechnology Revenue  $32,000 

 

Securities and Investment Management Revenue Information:

 

Three months ended September 30, 2026    
Rental   $162,000 
Commission   45,000 
Total Securities Revenue  $207,000 

 

Three months ended September 30, 2025    
Rental  $702,000 
Commission   737,000 
Total Securities Revenue  $1,439,000 

 

Nine months ended September 30, 2026    
Rental  $522,000 
Commission   160,000 
Total Securities Revenue  $682,000 

 

Nine months ended September 30, 2025    
Rental  $2,099,000 
Commission   1,241,000 
Total Securities Revenue  $3,340,000